Health Care: Drugs

ISIS Pharmaceuticals Inc (ISIS: NASDAQ)

$54 -1.43 | -2.58%
07/07/15 - 11:27 AM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 214.16M 147.28M 102.05M 99.09M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 214.16M 147.28M 102.05M 99.09M
Selling, General, and Administrative Expenses 20.14M 14.92M 12.52M 12.79M
Research & Development 241.75M 184.03M 158.46M 157.40M
Operating Income before D & A (EBITDA) -47.73M -51.67M -68.92M -71.10M
Depreciation & Amortization 33.07M 28.68M 30.51M 26.25M
Interest Income 2.68M 2.08M 1.84M 2.41M
Other Income - Net 12.87M 2.38M 15.05M 4.18M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -65.25M -75.88M -83.94M -94.31M
Interest Expense 22.21M 19.36M 21.15M 16.73M
Pre-Tax Income -87.46M -95.24M -105.09M -111.04M
Income Taxes -15.41M -5.91M -9.11M 11.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -38.98M -60.64M -65.48M -84.80M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -38.98M -60.64M -65.48M -84.80M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -38.98M -60.64M -65.48M -84.80M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-38.98M -60.64M -65.48M -84.80M
Preferred Dividends
Net Income Available To Common -38.98M -60.64M -65.48M -84.80M
Basic EPS from Continuing Ops. -0.33 -0.55 -0.65 -0.85
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.33 -0.55 -0.65 -0.85
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.33 -0.55 -0.65 -0.85
Basic Normalized Net Income/Share -0.33 -0.55 -0.65 -0.85
EPS fr Continuing Ops. -0.33 -0.55 -0.65 -0.85
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.33 -0.55 -0.65 -0.85
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.33 -0.55 -0.65 -0.85
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.33 -0.55 -0.65 -0.85
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ISIS

Latest ISIS Headlines from TheStreet

More Financial News for ISIS

Press Releases for ISIS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter